Test first. Because the best treatment for your stomach cancer can be individualized. Learn more: TestYourBiomarkers.org GICancersAlliance.org @hanscooks

Human Epidermal Growth Factor Receptor 2 (HER2) is a genetic biomarker. The HER2 gene makes HER2 proteins. Stomach cancer cells containing a higher-than-normal amount of HER2 protein can grow quickly and spread. These tumors can be treated with targeted antibody drugs.

Thank you to our founding supporter @AstellasUS for your dedication and commitment to raising biomarker testing awareness in treating stomach cancer. Learn more about their relentless pursuit of scientific progress and identifying unmet medical needs. bit.ly/3UFAJ0U

Clinical trials are key to advancing treatment for stomach cancer. There are many places to explore relevant trials for your type of stomach cancer. Save for Later! ClinicalTrials.gov @ResearchMatch @FindMeCure centerwatch.com @theNCI @GastricCancerFD

Sharing your experiences with biomarkers and stomach cancer may help someone with this rare disease make a decision that improves or lengthens their life. Share these informational posts with your social networks, or download some editable graphics from testyourbiomarkers.org

Biomarkers can be tested for in biopsies or in blood. It is important to test for biomarkers as every stomach cancer is unique, and testing early ensures that you and your healthcare team can identify the very best personalized treatment options – now and in the future.

DID YOU KNOW - There are currently 6 common stomach cancer biomarkers. Her2, MSI-high and dMMR, PD-L1, TMB, EBV, and Tumor agnostic. There are also emerging biomarkers: As new biomarkers are identified and researched, more individualized treatment will become available.

Test Your Biomarkers is a collaborative effort where researchers, oncologists, patients, advocacy groups, and caregivers are dedicated to providing newly diagnosed stomach cancer patients with accurate biomarker information, helping them make the right treatment decisions.

Early biomarker testing has the potential to impact a patient’s stomach cancer diagnosis, prognosis, and treatment. Not all stomach cancers have the same biomarkers, and testing early ensures the very best personalized treatment options - now and in the future.

Thank you to our medical advisory committee members for your invaluable guidance in creating this much-needed resource. You are helping newly diagnosed stomach cancer patients access to potentially life-saving information about the importance of biomarker testing.

The high mortality rate associated with stomach cancer demands we raise awareness of and advocate for biomarker testing. We started the Test Your Biomarkers to raise awareness about the importance of biomarker testing in treating stomach cancer for patients and their loved ones.

Thank you to our founding supporter @NoStomach4Cancr for their commitment to raising biomarker testing awareness in treating stomach cancer. Learn more about the non-profit patient advocacy organization advancing awareness & education about stomach cancer: bit.ly/3KURo9G

Biomarkers are bits of information unique to you and your cancer. They can be genes, gene mutations, or proteins that cause cancer cells to grow and spread. It's important to check for stomach cancer biomarkers because new drugs can potentially target them and stop cancer growth.

Were you or someone you know just diagnosed with stomach cancer? You are not alone and we are here to help. Our website is full of resources for patients and caregivers to help along this journey. testyourbiomarkers.org/downl…

Thank you to Founding Supporter @Amgen for your dedication and commitment to raising awareness about the importance of biomarker testing in treating stomach cancer. Amgen is one of the world’s leading biotechnology companies. Click to learn more. amgen.com/about

MYTH- Stomach cancer is incurable FACT- Stomach cancer is treatable Talk to your healthcare team about biomarker testing. It is important to know which biomarker is driving your cancer and to disable that biomarker if a drug is available. Learn More: bit.ly/3Sur36Q

Microsatellite Instability High (MSI-high) are short, repeated strings of DNA; a stomach cancer biomarker. MSI-high cancer cells contain a high number of mutations, making them extra sensitive to drugs called immunotherapy checkpoint inhibitors. Learn more bit.ly/3I7MHJd

MYTH- All stomach cancers are the same, and every patient has the same treatment plan. FACT- Stomach cancers are NOT all the same, and each patient’s type of stomach cancer has a unique set of biomarkers. Learn more about Biomarkers on our site testyourbiomarkers.org

Biomarker PD-L1 (Programmed Death-Ligand-1) Tumor cells containing high amounts of a protein PD-L1, targeted drugs nivolumab (Opdivo) & pembrolizumab (Keytruda) prevent the suppression of T cells and free up the immune system to fight cancer. Learn more: bit.ly/3I7MHJd

Human Epidermal Growth Factor Receptor 2 (HER2) is a genetic biomarker. The HER2 gene makes HER2 proteins. Stomach cancer cells containing a higher-than-normal amount of HER2 protein can grow quickly and spread. These tumors can be treated with targeted antibody drugs.